Cannabis News Box

Cannabis study: Whole-plant cannabis is more powerful at treating epilepsy than CBD

Cannabis study: Whole-plant cannabis is more powerful at treating epilepsy than CBD

Bethan Rose Jenkins, Cannabis News Writer/Editorial

October 5, 2018


Filed under Medical cannabis, Research

The number of cannabis studies demonstrating the plant’s medical potency for the treatment of epilepsy, among many other ailments, is rapidly increasing.  In June, the Food and Drug Administration (FDA) approved a cannabis-based medicine for epileptic patients, known as Epidiolex. The drug, which w...

Cannabis-based epilepsy treatment Epidiolex will cost $32,500 annually

Cannabis-based epilepsy treatment Epidiolex will cost $32,500 annually

Bethan Rose Jenkins, Cannabis News Writer/Editorial

August 29, 2018


Filed under Medical cannabis, News

Epilepsy sufferers may never have to worry about enduring bouts of life-threatening seizures ever again, thanks to the Food and Drug Administration (FDA) approving the world’s first ever cannabis-derived medication for the treatment of two rare types of pediatric epilepsy. The discussion surrounding ...

Great Britain prepares to legalize cannabis for medicinal use

Great Britain prepares to legalize cannabis for medicinal use

Bethan Rose Jenkins, Cannabis News Writer/Editorial

August 3, 2018


Filed under Global, News

Medical cannabis is set to become available on prescription in the UK after the government approved a law to permit medicines derived from the cannabis plant. According to the Home Office, cannabis-based medicines can be legally prescribed by general practitioners “by the autumn.” “Following advice f...

CEO of GW Pharma talks about Epidiolex getting FDA approval

CEO of GW Pharma talks about Epidiolex getting FDA approval

Bethan Rose Jenkins, Cannabis News Writer/Editorial

July 2, 2018


Filed under Medical cannabis, News

On Monday, Justin Gover hit a milestone in his career. He is the CEO of GW Pharmaceuticals – a company that created a cannabis-based medicine called Epidiolex. Not only is Epidiolex being used to treat two forms of epilepsy but also, it is non-psychoactive, what with it containing the cannabis com...

Will Epidiolex be the first cannabis-based drug to be approved as an epilepsy treatment?

Will Epidiolex be the first cannabis-based drug to be approved as an epilepsy treatment?

Bethan Rose Jenkins, Cannabis News Writer/Editorial

May 3, 2018


Filed under Medical cannabis

A cannabis-based medication for epilepsy could be the first to gain approval by the Food and Drug Administration (FDA). Created by British company GW Pharmaceuticals, cannabis-based epilepsy treatment Epidiolex will undergo FDA review this June. Things are looking hopeful, with a panel of 13 advisors...

FDA gives positive review for GW Pharmaceuticals’ cannabis-based medicine Epidiolex

FDA gives positive review for GW Pharmaceuticals’ cannabis-based medicine Epidiolex

Bethan Rose Jenkins, Cannabis News Writer/Editorial

April 19, 2018


Filed under Medical cannabis, News

Epidiolex, a cannabis-based treatment for epilepsy from GW Pharmaceuticals, received a positive review from staff at the Federal Drug Administration (FDA) on Tuesday. GW Pharmaceuticals provided “substantial evidence” to prove the drug’s suitability for treating two rare types of epilepsy. ...

GW Pharmaceuticals